// App-Quantinova.ai

23 : Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Researchers

Presenter

  • Catherine M. Broome

Principal Investigators

  • Alexander Rth

  • David J. Kuter

  • Marie Scully

  • Roy Smith

  • Jennifer Wang

  • Xiaoyu Jiang

  • Caroline Reuter

  • Ahmed Daak

  • William Hobbs

Medical Centers

  • Division of Hematology and Oncology, MedStar Georgetown University Hospital, Washington, DC

  • West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany

  • Division of Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Department of Haematology, University College London Hospitals, Cardiometabolic Program,National Institute for Health Research UCLH/UCL Biomedical Research Centre,London,United Kingdom

  • Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA

  • Sanofi, Waltham, MA.

Locations

  • Germany

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Immune thrombocytopenia

  • Migraine

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved